How do I hire an interim CRO for a biotech company in 2027?
Direct Answer
You hire an interim CRO for a biotech company in 2027 by first clarifying whether you need a fractional CRO (part-time, strategic, 2-4 days per week) or a full-time interim CRO (temporary, 5 days per week, often with a 6-12 month commitment). The core challenge is finding someone who understands biotech's long sales cycles, compliance-heavy buyer journeys, and the specific dynamics of selling to academic labs, hospital systems, or pharmaceutical R&D departments. Most strong fractional CROs in biotech work remotely or hybrid, so geographic proximity matters less than network access and regulatory familiarity. Expect to pay $15,000–$40,000 per month for a fractional role, or $30,000–$60,000 per month for a full-time interim placement, with the range driven by company stage (pre-revenue vs. Series B+), scope (just sales vs. full go-to-market), and the candidate's prior biotech exits.
Why Biotech Is Different from General SaaS
Biotech revenue leadership is not a vertical specialization you can pick up in a few months. The buyers—whether at a pharmaceutical company, a clinical reference lab, or a university research institute—operate on timelines that make enterprise SaaS look fast. A typical deal cycle runs 12 to 36 months, with procurement gatekeepers who require proof of CLIA certification, FDA clearance, or ISO 13485 compliance before they will even schedule a demo. An interim CRO who only knows how to accelerate SaaS sales will misprice contracts, miss compliance milestones, and frustrate your scientific team.
The revenue motion is also different. Biotech often sells through distributors, group purchasing organizations (GPOs), or key opinion leaders (KOLs) who influence purchasing decisions without signing contracts. Your interim CRO must know how to manage these indirect channels, not just direct sales. They should be able to walk into a board meeting and discuss reimbursement strategy, regulatory risk, and clinical validation as fluently as they discuss quota attainment.
Fractional vs. Full-Time Interim: Which One Fits Your Stage?
The table above gives you the mechanical differences, but the stage of your biotech company is the real deciding factor.
If you are pre-revenue or early-stage (seed to Series A) with fewer than 3 salespeople, a fractional CRO is almost always the right call. You don't need someone sitting in your office every day. You need a strategic brain who can help you define your ideal customer profile, build a pricing model that works for both academic budgets and pharma margins, and coach your founder-led sales efforts. A fractional CRO at $15,000–$25,000 per month for 2-3 days per week gives you that without burning cash.
If you are Series B or later with a team of 5+ account executives, a full-time interim CRO may be necessary. At this stage, you likely have revenue operations, customer success, and marketing teams that need daily coordination. A part-time leader can't attend every pipeline review, handle every escalation, or build the compensation plans and territory assignments that a growing team requires. The cost is higher—$30,000–$60,000 per month—but so is the accountability.
How to Vet a Fractional CRO for Biotech
The standard fractional CRO vetting process—review LinkedIn, check references, ask about quota attainment—is not enough for biotech. You need to probe for specific domain knowledge.
Ask these questions during interviews:
- "Describe a time you navigated a compliance hurdle in a biotech sale. What was the regulatory body, and how did you adjust the sales process?" A strong candidate will name a specific agency (FDA, CLIA, ISO) and describe how they worked with legal or quality assurance to get the deal through.
- "How do you handle a 24-month sales cycle when your board expects quarterly growth?" Look for answers that include milestone-based forecasting, stage-gating, and managing expectations with investors. Avoid candidates who promise to "compress the cycle" without understanding the science.
- "What's your experience with GPOs or distributor networks in biotech?" Even if your company sells direct, the candidate should understand how these intermediaries work, because your buyers may be influenced by them.
- "Can you name three biotech companies where you've worked, and what was your specific role?" Don't accept vague answers like "I advised a diagnostics startup." Demand specifics: company name (or at least sector), stage, and whether they were fractional or full-time.
The Onboarding Process: What to Expect in the First 90 Days
A well-structured onboarding for a fractional CRO in biotech should follow a clear timeline.
Days 1-30: Audit and Diagnosis. The CRO should spend this time reviewing your CRM (Salesforce or HubSpot), interviewing your existing sales team (if any), and mapping your current pipeline. They should produce a 30-day audit report that includes: deal stage definitions, conversion rates by stage, average deal size, buyer personas, competitive positioning, and any compliance gaps in your sales materials. They should not be setting revenue targets or making changes to your comp plan yet.
Days 31-60: Process Design and Quick Wins. With the audit complete, the CRO should design a revenue process tailored to your biotech buyers. This might include: a new qualification framework that accounts for regulatory timelines, a pricing guide that works for both academic and pharma buyers, and a sales playbook for your team. Quick wins might include cleaning up stale pipeline, re-engaging lost deals with new messaging, or adjusting your demo sequence to address compliance questions earlier.
Days 61-90: Execution and Measurement. By month three, the CRO should be actively coaching your team, running weekly pipeline reviews, and reporting to the board on leading indicators (pipeline velocity, stage progression, demo-to-proposal conversion). Revenue growth may still be modest, but you should see clear improvements in process discipline and forecast accuracy.
Cost Drivers and Negotiation Levers
The monthly fee for a fractional CRO in biotech depends on several factors:
- Days per week: 2 days/week costs less than 4 days/week. Most fractional CROs charge a daily rate of $1,500–$3,000, so a 2-day week is $12,000–$24,000 per month, while a 4-day week is $24,000–$48,000.
- Stage and complexity: Pre-revenue biotech with no team is simpler and cheaper. A Series B company with 10 sellers, a channel partner program, and complex compliance requirements will command the higher end.
- Cash vs. equity: Fractional CROs rarely take equity, but for pre-seed biotech with limited cash, some will accept a small equity grant (0.5-1%) in exchange for a lower cash fee. This is negotiable but uncommon.
- Travel: If you require on-site visits (e.g., to your lab or office), expect to pay for travel expenses or a higher daily rate. Most fractional CROs are remote-first, so this is usually avoidable.
When Not to Hire a Fractional CRO
Fractional CROs are not a cure-all. Avoid hiring one if:
- Your product is not ready for market. If you are still in clinical trials or have not achieved regulatory clearance, no CRO can sell effectively. Focus on getting the science right first.
- You have no sales team and no budget for one. A fractional CRO can coach you on founder-led sales, but they cannot be your only seller. You need at least one full-time person (even if it's you) to execute.
- You need a full-time operator, not a strategist. If your company is in crisis—churn is high, team is dysfunctional, board is losing patience—you may need a full-time interim CRO who can be present daily. A fractional leader may not have the bandwidth.
- You are unwilling to change your process. The best fractional CROs will challenge your assumptions about pricing, targeting, and sales methodology. If you are not open to that, the engagement will fail.
FAQ
What's the difference between a fractional CRO and a sales consultant? A fractional CRO is an embedded leader who takes ownership of revenue outcomes, attends board meetings, and manages the team. A sales consultant typically delivers a report or training and leaves. For biotech, you need the former—someone who can be accountable for pipeline and process over months, not days.
How do I find a fractional CRO with biotech experience? Start with Pavilion (joinpavilion.com) and RevOps Co-op (revopscoop.com) for referrals. Also ask your investors—biotech VCs often have a network of fractional operators. LinkedIn searches for "fractional CRO biotech" can work, but vet carefully using the questions above.
Can a fractional CRO work remotely for my biotech company? Yes, most fractional CROs work remotely. Biotech's long sales cycles mean that in-person meetings are less critical than process and strategy. However, if your company is early-stage and you need hands-on coaching of a junior team, some on-site time (e.g., 1-2 days per month) can help.
What if I need to terminate the contract early? Negotiate a 30-day out clause in your contract. Most fractional CROs will agree to this. You pay for the notice period, and they help transition knowledge to your team. Avoid contracts with large termination fees.
How do I measure success for a fractional CRO in biotech? In the first 90 days, measure process improvements (pipeline hygiene, forecast accuracy, stage definitions), not revenue. After 6 months, look for pipeline velocity (shorter time from demo to proposal) and win rate improvements. Revenue growth may take 12-18 months due to long cycles.
Should I hire a fractional CRO or a VP of Sales? A fractional CRO is a strategic leader who owns the entire go-to-market (sales, marketing, customer success). A VP of Sales is a tactical manager focused on closing deals. If you need someone to build the revenue engine from scratch, hire a fractional CRO. If you have a working engine and just need a closer, hire a VP of Sales.